Patents by Inventor Giovanni Sanso

Giovanni Sanso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE PREPARATION OF CONTROLLED-RELEASE SOLID FORMULATIONS CONTAINING OXCARBAZEPINE, AND FORMULATIONS OBTAINABLE BY SAID PROCESS
    Publication number: 20100226944
    Abstract: The present invention relates to a process for the preparation of controlled-release solid oral pharmaceutical formulations of oxcarbazepine, and the pharmaceutical formulations obtainable by said process.
    Type: Application
    Filed: July 23, 2008
    Publication date: September 9, 2010
    Applicant: ARCHIMICA S.R.L.
    Inventors: Giovanni Sanso', Aldo Banfi, Giorgio Bertolini, Claudio Silva
  • Method for synthesizing 5-chloro-1-aryl-4-(4,5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives
    Patent number: 7678923
    Abstract: Method for synthesising 1-aryl-4-(imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives from 1-aryl-3-alkyl-1H-pyrazo-line-5-one derivatives.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: March 16, 2010
    Assignee: EVULTIS
    Inventors: Alessandro Mazzola, Giovanni Sanso
  • Method for synthesing 5-chloro-1-aryl-4-(4,5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives
    Publication number: 20070155811
    Abstract: Method for synthesising 1-aryl-4-(imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives from 1-aryl-3-alkyl-1H-pyrazo-line-5-one derivatives.
    Type: Application
    Filed: April 9, 2004
    Publication date: July 5, 2007
    Applicant: EVULTIS
    Inventors: Alessandro Mazzola, Giovanni Sanso
  • Double capsule for the administration of active principles in multiple therapies
    Patent number: 6350468
    Abstract: A pharmaceutical dosage form particularly suitable for the administration of active principles in multiple therapies is disclosed. The pharmaceutical dosage form is a double capsule where in an internal capsule is placed inside an external one. Each internal and external capsule includes one or more active principles. A double capsule according to the invention is preferably used in triple or quadruple therapies against the microorganisms Helicobacter Pylori. Advantages of this pharmaceutical dosage form consist in providing a simple posology for administration of two and more active principles, allowing the active principles to activate at the right intervals of time and in the preestablished quantities, and preventing interactions between active principles.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: February 26, 2002
    Assignee: Axcan Pharma Inc.
    Inventor: Giovanni Sanso